SNDL
SNDL
NASDAQ · Pharmaceuticals

Sndl Inc

$1.41
+0.05 (+3.68%)
As of May 9, 1:51 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +1,045.4% upside
Low Target $10.52
Average Target $16.15
High Target $19.28
Current Price $1.41
Current
$1.41
Target
$16.15
$10.52 $16.15 avg $19.28
Scenario Analysis
Bear Case
$10.52
646.1%
Low target
Base Case
$16.15
+1,045.4%
Avg target
Bull Case
$19.28
+1,267.4%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.89
-51.2% from high
52-Week Low
$1.15
+22.6% from low
Target vs 52W High
$16.15
+458.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%